optimizing neurodevelopment without increasing metabolic risk
DESCRIPTION
Objectives Describe the influence of early growth and nutrition on later neurodevelopment in various populations, including SGA and AGA term and preterm infants. Recognize potential trade-offs to accelerated growth in various populations. Describe various methods of growth measurement available for neonates and the importance of following length and body composition in addition to weight gain.TRANSCRIPT
Optimizing Neurodevelopment without increasing Metabolic
Risk
Sara Ramel, MD Division of Neonatology University of Minnesota
Masonic Childrens Hospital Minneapolis, MN Objectives Describe the
influence of early growth and nutrition on later neurodevelopment
in various populations, including SGA and AGA term and preterm
infants. Recognize potential trade-offs to accelerated growth in
various populations. Describe various methods of growth measurement
available for neonates and the importance of following length and
body composition in addition to weight gain. Improved/Increased
Nutrition
Improved Growth Improved Neurodevelopment Given the tremendous
changes occurring in the brain throughout pregnancy, infancy and
childhood it is not surprising as well that early nutrition and
growth have a strong influence on later cognition. Therefore it has
been long agreed that improved nutrition will lead to improved
growth and in turn improved neurodevelopment. In some areas this
continues to be true but as nutritional and outcomes research has
evolved it has become much more complicated with more rapid weight
gain benefitting some infants by improving neurodevelopment and
harming others by increasing risk for later obesity and metabolic
syndrome. MORE may not be better!! Weight gain cannot be the only
metric used to determine optimal growth. Early life experiences
have long-term effects on many body systems
Strong evidence to support that sub-optimal in-utero growth leads
to increase risk of later metabolic disease in certain populations
It is becoming increasingly clear that early life experiences (both
nutritional and non-nutritional) and in-utero and in infancy have
lasting effects on many body systems. There is also good data to
show that suboptimal in-utero growth, especially when combined with
rapid post-natal growth acceleration, leads to an increased risk of
metabolic disease in later life in certain populations. Most
specifically a strong association has been shown between term
growth restricted infants who later experience insulin resistance.
Given this surge of new data, initially focused specifically on SGA
term infants, along with the data supporting increased growth and
its benefit to later neurodevelopment we must ask the question is
more better and is it the same for all infants? Neurocognitive
Development
Rapid Infant Growth More rapid infant weight gain is associated
with long term benefits, such as better neurodevelopmental outcomes
for some infants, but also with harms, such as increased risk of
obesity and metabolic syndrome. Determining the optimal rate of
growth requires balancing these benefits and risks, the magnitude
of which differ for specific populations. Obesity, Metabolic
Syndrome Risk Preterm Infants Weight gain, Linear Growth and
Fat-Free Mass Gains
Energy and Protein Improved Neuro- development You remember from my
previous talk that in preterm infants specifically improved growth
both while in the NICU and after hospital discharge, periods during
which tremendous growth and development of the brain are occurring,
are associated with improved neurodevelopment. Specifically,
increases in weight, length and fat free mass gains improve speed
of processing, language, cognitive and motor scores and decrease
rates of cerebral palsy. Also, we discussed that increased amounts
of calories and protein given early lead to not only improved
growth throughout infancy but also improved neurodevelopment.
Metabolic Risk in Preterm Infants?
Reduced insulin sensitivity Increased risk to develop type II
diabetes Elevated blood pressure and resting heart rate Increased
low-density lipoprotein Higher truncal fat Why not just give more
and see if we can improve later neurodevelopment. Given concerns
for increased adiposity among preterm infants after hospital
discharge coupled with the large increase in concern about negative
consequences of catch-up growth in other growth restricted
populations it is tempting to apply that same degree of concern to
preterm infants who undergo growth restriction after birth. Is it a
real concern?? Multiple large studies and systematic reviews have
recently been published stating that preterm birth alone is
associated with reduced insulin sensitivity elevated blood pressure
and resting heart rate and slightly increased low-density
lipoprotein Tinnion R. Arch Dis Child. 2014 Parkinson JRC.
Pediatrics. 2013 de Jong F. Hypertension. 2012 Kerkhof GF. J
Pediatr Meta-analysis of 10 observational studies (Preterm vs Term
SBP)
Childhood BP ~2.5 mmHg higher in preterm Twice as likely to be
hypertensive as adults In adolescence and young adulthood former
preterm infants have ~ 2.5 mm Hg higher systolic BP than full-term
infants. And are twice as likely to be hypertensive as adults. de
Jong F. Hypertension. 2012 Metabolic risk is real for preterm
infants
Metabolic risk is real for preterm infants. is it due to rapid
growth or excess nutrition?? Nutrition and Metabolic Risk
Several studies documenting increased Fat Free Mass (NOT FAT MASS)
with increased calories and protein Infants on fortified feeds have
higher fasting insulin levels Preterm infants who received more
aggressive nutrition during the first 2 weeks of life remained
taller and heavier as adolescents No increase in percent body fat,
systolic or diastolic BP Costa-Orvay. J Nutr 2011 Rachow N. Clin
Nutr. 2011 Ramel SE. JPGN 2011 Ludwig-Auser H. Chin. J Contemp
Pediatr. 2013 Singhal A. Lancet. 2003; Growth and Metabolic
Risk
Early differences in body composition resolve Multiple studies
revealing no association between early growth and later HTN, lipid
profiles and insulin sensitivity Increased BMI and weight gain in
first 1-2 years post-term associated with obesity in childhood
Childhood growth (>18 months) has shown small associations with
metabolic syndrome While it is clear that risks for the components
of metabolic syndrome are high in preterm infants what isn't as
clear is whether these risks are due to nutrition and growth in
early infancy, a time when the benefits for this growth are clear.
The evidence linking weight gain and later metabolic risks are very
inconsistent. Pfister Kand Ramel SE. Current Pediatrics. 2014
Belfort M. Nestle Nutr Inst Workshop Ser. 2013 Growth and Metabolic
Risk
More study needed on early growth Early aggressive nutrition Avoid
early growth restriction and need for catch-up growth Monitor
proportionality and linear growth and potentially body composition
Neurocognitive Development
PRETERM Rapid Infant Growth Among preterm infants vulnerable to
neurodevelopmental impairment the rationale is strong to promote
rapid growth even out of proportion to linear growth early by
aggressive nutrition early in life. After term excess weight gain
in proportion to length is unlikely beneficial and may increase
risk of later metabolic complications. Later rapid growth
especially after one year of life is unlikely to provide additional
neurodevelopmental benefit and will increase later risk. Obesity,
Metabolic Syndrome Risk Small for Gestational Age Term
Infants
Rapid growth in weight and length in the first months after birth
Most catch up to peers by 6-12 months Poorer neurodevelopmental
outcomes than AGA term infants More prone to later metabolic
disease Given the extensive literature on preterm infants and the
benefits of aggressive nutrition the question arises what about SGA
term infants. Those that undergo growth restriction while in utero.
How much weight gain is optimal
How much weight gain is optimal? Infant weight gain in IUGR
infants: BMI and IQ at 7 years Given the metabolic harms it is
important to also look at the potential benefits of rapid weight
gain to later neurodevelopment. Most studies that look at SGA
include both term and preterm despite the fact that the benefits
and risks may be different. Only study that separated term from
preterm SGA and looked specifically at early growth This is an
analysis of Collaborative Perinatal Project data . Both slower and
more rapid weight gain from birth to 16 weeks was associated lower
IQ at age 7 years. National Collaborative Perinatal Project Data
Pylipow et al., 2008, J. Peds. Fortification for SGA Term
Infants
Increased calories (68 vs 72 kcals/100 mls) and protein (+0.4
g/100mls) Given for 9 months Improved length and OFC gains at 9 and
18 months Similar IQ scores at 18 months (MDI 88.6 vs 87) and PDI
(90.4 vs 90.7) Control BF group with much improved scores (MDI 99.5
and PDI 96.5) 9 month DQ actually worse in fortified group
Singhal.AJCN, 2010 Morely. Pediatrics. 2004 Later Metabolic
Outcomes
Several studies linking rapid weight gain in first 4 months to
increased BMI, higher BP and insulin resistance at school
age/adolescence Body composition and cardiometabolic risk factors
assessed at follow-up (6-8 years of age) Fat Mass Standard: 2.0 kg
Enriched: 2.7 (p=0.04) FFM Standard: 19.3 Nutrient: 19.8 (p=0.2)
Blood Pressure Standard: 61.3 Enriched: 64.5 (p=0.02) Enriched =
20% formula in relationto energy 284 kJ/100 ml energy vs enriched =
301 kJ/100 ml 0.4 more grams of protein Singhal et al. AJCN. 2010
Singhal. Circulation. 2007 Neurocognitive Development
TERM SGA Rapid Infant Growth While full term SGA infants are at
risk relative to AGA in terms of both neurodevelopmental deficit
and cardio-metabolic disease later in life, more rapid growth
likely leads to increased risk for insulin resistance, high BP and
increased FM but does not appear to improve neurodevelopmental
outcomes. More rapid infant weight gain is associated with long
term benefits, such as better neurodevelopmental outcomes for some
infants, but also with harms, such as increased risk of obesity and
metabolic syndrome. Determining the optimal rate of growth requires
balancing these benefits and risks, the magnitude of which differ
for specific populations. Obesity, Metabolic Syndrome Risk AGA
Healthy Term Infants
No positive association between rapid weight gain and IQ at 49
months or 8 years No linear association between weight gain or
linear growth and IQ Systematic literature review of 14 studies
that addressed associations between any kind of early weight gain
and cognitive outcome in non-SGA children. Rapid weight gain was
identified as increase of >0.67 in the SD score of weight or
length between birth and 25 months of age. No positive association
between rapid weight gain and IQ scores either at 49 months or 8
years. Subgroup analysis by sex of children and with rapid length
gain revealed similar results. Supplementary analysis revealed no
linear association between weight gain and IQ. Beyerlein A. Am J
Clin Nutr 2010 Healthy AGA Term Infants
US cohort of ~900 infants Neither weight gain from birth to 8 weeks
nor from 8 weeks to 6 months was related to cognition at age 3
years (or 7 years-unpublished). Additional dutch study of twins in
adolescnece showed lower IQ by 3.2 points in the twin who gained
greater weight (p=0.002). Belfort MB. Pediatrics. 2008 Metabolic
Risk In Term Infants
In a systematic review of 21 studies, all reported positive
associations of infant weight gain and later obesity risk. For each
0.67 SD excess weight gain from birth to 4-24 months, obesity risk
increased fold! Other reviews have also found positive associations
with increased BP and increased metabolic score as well. Ong KK.
Acta Paediatr. 2006 Neurocognitive Development
TERM non-SGA Rapid Infant Growth In AGA term populationample data
supporting a strong association between rapid infant weight gain
and later obesity and limited evidence regarding other
cardio-metabolic disease risk factors. In contrast, studies of
early weight gain and later neurodevelopmental outcomes have shown
small to no associations. Obesity, Metabolic Syndrome Risk Goals of
Growth Growth goals to replicate fetal growth per AAP
Unclear if this is achievable and/or optimal The American Academy
of Pediatrics has recommended that growth goals for preterm infant
replicate that of fetal growth. Unfortunately, whether this goal is
achievable OR optimal remains to be seen 3 decades after this
recommendation was made. Determining optimal growth goals requires
studies collecting long-term outcome data not only on growth, but
also neurodevelopment and metabolic outcomes. This work is
beginning to be done, but there is still much more to learn. AAP
Committee on Nutrition. Pediatrics 1985;75:97686 Definitions of
Growth Weight Gain Head Circumference Linear Growth
Proportionality Indices Body Composition I will now finish my talk
with a discussion on methods of growth monitoring in neonates, as
this is still the best method of determining the adequacy of
nutrient intake. As previously mentioned, adequate and/or optimal
growth has been defined as weight gain for the past several
decades. Until recently publications addressing growth and later
outcomes were based solely on this measure. This is likely because
it is the easiest measure to obtain and most accurate measure
obtained in the clinical setting. In the past several years as I
have now shown you, the importance of linear growth and FFM gains
have also been investigated. Linear growth and FFM accretion are
more closely associated with organ growth (specifically the brain)
and are important biomarkers of later cognitive outcomes. However,
length can be a more difficult measure to obtain and requires
appropriate equipment (length boards) to obtain accurate repeated
measures. Weight for length measures have become more popular
recently as a marker of proportionality and surrogate for true body
composition measures. These measures have been shown to be
appropriate for older children and adults, but have not been
validated in young infants or preterm infants yet. Body composition
devices are available but remain expensive and therefore not
routinely used outside of the research setting yet. Weight Gain
Weight gain alone does not give a clear picture of nutritional
status Recommended weight gain velocity is g/kg/d to mimic fetal
growth Does not account for catch-up often needed in ELBWs who had
very poor or no weight gain initially May need g/kg/d Weight gain
is the traditional metric of growth in the neonate and represents
the balance between energy intake and expenditure. Although weight
gain is associated with neurodevelopmental outcomes and there are
distinct recommendations for rates of weight gain in preterm
neonates, this metric alone does not give a complete picture of the
overall nutritional state of the infant, and can be confounded by
non-nutritional weight gain (eg, edema). While fetal weight gain is
approximately grams per kilo per day, this goal does not account
for the significant growth restriction that occurs in the first
weeks of life amongst preterm infants. For this reason, a better
goal for optimizing growth and neurodevelopment is likely closer to
grams per kilo per day of weight gain. Head Circumference Goal ~1
cm/week Correlates with brain growth
Microcephaly associated with loss of gray matter1 Suboptimal head
growth (1-2 SD below norm) associated with poorer
neurodevelopmental outcomes2 Fetal head circumference gains are
approximately 1 cm per week and correlate with brain growth.
Microcephaly has been shown to be associated with loss of gray
matter. Also, while head circumference appears to be relatively
spared when compared to weight and linear growth, up to 30% of
preterm infants continue to have suboptimal head growth. This
suboptimal growth has also been associated with poorer
neurodevelopment. For these reasons, head circumference should be
measured at least weekly and if restriction occurs early, catch up
growth should be monitored and optimized with goals of at least 1
cm per week. 1Cheong, Pediatrics 2008 2Neubauer, Acta Paediatrica
2013 Linear Growth Represents lean body mass, protein accretion and
indexes organ growth Goal ~1-2 cm/wk Linear growth which represents
lean body mass and protein accretion, is an often underutilized
measurement. It is obviously a difficult measurement to obtain in
utero and therefore fetal linear growth rates are difficult to
interpret. This figure is looking at fetal crown heel length growth
throughout gestation with age in weeks along the x axis and crown
heel length velocity in centimeters per 4 weeks along the y axis.
As you can see, fetuses between 20 and 30 weeks grow more than 1 cm
per week and in fact closer to 2 cm per week. Linear growth should
be measured weekly using a length board to be most accurate with
goals of 1-2 cm per week. As length is an important marker of brain
development, it should be followed closely and optimized as able.
Crown-heel length velocity, cm per 4 weeks of gestational age. From
Tanner JM Foetus Into Man. Cambridge, Massachusetts. Harvard
University Press. BMI curves BMI measurement may help identify
disproportionate growth
What is the ideal BMI for growing preterm infants? BMI is
correlated with body fatness and risk of related diseases in
children >5 years and adults. Proportionality indexes are
proposed as complementary measures in neonatal growth assessment,
but are not commonly used in neonates. Recently Olsen et al
published BMI curves for preterm infants which may allow for closer
monitoring of proportionality amongst this group of at risk
infants. Unfortunately, what remains unclear is what is the ideal
BMI for growing preterm infants. Hopefully, the release of these
curves will now allow for studies looking at longitudinal changes
in BMI and outcomes both neurodevelopmental and metabolic. Olsen et
al. Pediatrics. 2015 BMI in Term Born Infants
Body mass index or BMI is correlated with body fatness and risk of
related diseases in children ages 5 years through adulthood.
Proportionality indexes have also been proposed as complementary
measures in neonatal growth assessment, but are not yet commonly
used in this population. This study published in looked at 200 term
neonates and found strong associations between BMI and body fat %.
However, the predictive value was quite poor given the large amount
of variability seen at each z-score. As you can see on this scatter
plot comparing BMI z-scores to % body fat, a BMI z-score of
0(click) is consistent with a body fat percent ranging from 2%
(click) to as high as 17% (click). DeCuntoet al.Arch Dis Child
Fetal Neonatal Ed 2014. All Proportionality Indices Poorly Predict
%Body Fat
The best predictor was BMI (W/L2) Another uncertainty is whether
BMI is an accurate predictor of body composition in newborns and
specifically preterm infants. We performed an analysis on 218
preterm infants born between weeks gestation who had their body
composition measured near birth. We looked at associations between
multiple proportionality indices and body composition and found
that all measures including BMI, ponderal index and weight for
length are poor predictors of body fat percent. However,Weight for
length squared or BMI was the best predictor of those tested with
an R squared value of only As you can see on this scatter plot
comparing BMI to % fat mass these two measures are correlated, but
with a large amount of variance noted. For example, an infant with
a BMI of 10 (click) could have a percent body fat ranging from near
0% (click) to 20%. A similar analysis was performed in term infants
with similar findings. Body Composition Measurement
DEXA MRI Air Displacement Plethysmography Anthropometric Measures
Isotope Dilution Bioelectrical Impedance Analysis While this area
of research, specifically for preterm infants, remains relatively
young, increases in the availability of devices allowing for infant
body composition assessment have allowed for a surge of data on
body composition. The chart in the top left corner is an
illustration of this massive increase in publications on infant
body composition between 1952 and 2012.ranging from 0.95) Validated
against gold standard methods More Rapid than DXA, MRI, dilution
methods Lower cost than DXA and MRI Does not require highly trained
technician to operate Does not expose to radiation or require
sedation Well-tolerated by infants Has extensions for older infants
and young children 2-6 years, and for children and adults 6 and
above Air displacement plethysomography has many advantages over
other methods used for infant body composition. (click) It is
highly reliable and has been validated against gold standard
methods for both term and preterm infants. (click)Measurements are
quick lasting less than 5 minutes total. (click)While the equipment
is pricey it is much lower cost than MRI or DXA and since it does
not require a technician to operate once the equipment is purchased
there are not continued ongoing costs associated with its use.
(click)ADP does not expose to radiation or require sedation and is
(click)well tolerated by infants as young as 30 weeks gestation
shortly after birth. Finally, (click) there are extensions now
available allowing for longitudinal body composition tracking
through toddlerhood, childhood and adulthood! Ramel et al. Pediatr
Obesity 2014 Roggero et al. Pediatr Research 2012 ADP for Preterm
Infant Body Composition Measurement
Disadvantages: Infants must be stable for ~5 minutes on RA Infants
must be disconnected from all IVs and lines Uses constants for fat
and fat-free mass Expensive, large equipment Despite its many
advantages, there are still a few disadvantages to using ADP for
body composition measurement in preterm neonates. Perhaps the
biggest problem is that in order to be measured infants must be
able to tolerate ~ 5 minutes of time without being connected to any
respiratory support or IV lines. While most infants are able to
tolerate this once they reach the feeding and growing portion of
their hospital stay, this necessity limits the ability to measure
the smallest and sickest infants early on in their stay.
Additionally, the device measures volume and calculates density
using weight and length. It then uses constants for fat and fat
free mass to calculate the percent body fat and fat-free mass.
These values have been obtained using gold standard methods but the
differences between infants at different gestational ages as well
as different timing after birth are still being investigated.
Finally, the equipment remains expensive and large, especially when
compared to the cost and space taken up of a length board and scale
-Preterm in preparation
Growth curves developed from live-born infants are used as
standards for determining the adequacy of weight gain and linear
growth. Weight/Length and BMI Normative body composition along with
a body composition tool will allow for monitoring of quality of
weight gain. Term curves now exist -Preterm in preparation
Intrauterine growth curves that plot weight against gestational
ages have been developed from live-born premature infants and are
used as standards for determining the adequacy of weight gain of
individual infants (Lubchenco et al, Fenton, Babson and Benda)
Similarly, normative body composition data plotted against
gestational ages would allow for monitoring of the quality of
weight gain together with a body composition assessment tool
Preterm Infant Body Composition
Reference data on preterm infants using ADP As was discussed with
BMI, The first step in determining optimal body composition for
preterm infants is defining normal fetal gains in fat and fat free
mass. Unfortunately due to the number and rigor of measurements
needed for multicomponent body composition assessment, studies in
the past have been limited to very small numbers and performed on
still born infants and infants of varying ages up to several months
of age. With the advent of an infant ADP however it has become
possible to obtain rapid, non-invasive measurements on infants as
small as 1kg. We have collected cross-sectional data on fat and fat
free mass in ~220 infants born between 30 and 36 weeks gestation,
shortly after birth and will soon be submitting a manuscript
containing these growth curves with centiles for both fat and fat
free mass. Again, the goal of these curves was to represent as
closely as possible fetal fat and fat free mass accretion and will
hopefully allow us to determine what the ideal body composition is
in terms of long term metabolic and neurodevelopmental outcomes and
also aid in developing nutritional strategies to meet these goals.
Demerath et al. Manuscript in preparation. Summary Infant growth
must not be defined as weight gain alone!
Different Populations = Different goals, risks and benefits Amongst
preterm infants early rapid growth is beneficial More work on
timing of interventions and types of nutritional alterations
Non-nutritional factors Summary Term SGA infants early growth may
increase later metabolic risk without cognitive benefit. Term AGA
infants need closer growth monitoring to determine later risk
Further work into ideal formulas if breast milk is not
available